NIFTY 50▲22,402.40
34.40 (0.15%)
SENSEX▲73,852.94
114.49 (0.16%)
NIFTY BANK▲48,189.00
218.55 (0.46%)
TATA MOTORS▲991.65
4.90 (0.50%)
INDIAN RAILWAY FINANCE CORP▲149.00
1.25 (0.85%)
SUZLON ENERGY▼41.80
-0.05 (-0.12%)
TATA POWER▼428.30
-1.35 (-0.31%)
TATA STEEL▲165.55
4.40 (2.73%)
YES BANK▼25.45
-0.20 (-0.78%)
INDIAN RENEWABLE ENERGY▼166.60
-1.35 (-0.80%)
RELIANCE INDUSTRIES▼2,900.35
-18.30 (-0.63%)
RELIANCE POWER▼27.60
-0.40 (-1.43%)
VODAFONE IDEA▼13.10
-1.30 (-9.03%)
HDFC BANK▲1,511.70
4.10 (0.27%)
JIO FIN SERVICES LTD▼381.85
-6.10 (-1.57%)
RAIL VIKAS NIGAM▲284.25
6.90 (2.49%)
ADANI POWER▼596.50
-5.95 (-0.99%)
ZOMATO▼184.40
-3.05 (-1.63%)
NHPC▲90.25
0.50 (0.56%)
STATE BANK OF INDIA▲773.10
0.10 (0.01%)
INDIAN RAILWAY TOURISM CORP▲1,025.35
9.05 (0.89%)
INDIAN OIL CORP▲168.75
0.65 (0.39%)
MRF▼1,28,524.45
-702.25 (-0.54%)
ITC▼428.90
-0.30 (-0.07%)
ADANI GREEN ENERGY▼1,808.30
-8.10 (-0.45%)
JAIPRAKASH POWER VENTURES▼18.05
-0.20 (-1.10%)
ADANI ENTERPRISES▼3,043.55
-21.55 (-0.70%)
ADANI PORT & SEZ▼1,320.50
-1.60 (-0.12%)
Glenmark Life Science Share Price
GLS
₹822.15-₹4.10 (-0.5%) Past YearLast updated on 24 Apr, 2024 | 03:29 PM IST
₹822.15₹838.60
LH
What’s in news?
Company overview
About
Market cap
| Open₹835.95 | Close₹826.25 |
Circuit range₹908.85 - ₹743.65 | Day range₹822.15 - ₹838.60 | Year range₹456.00 - ₹906.00 |
Volume24,936 | Avg. traded₹830.69 | Revenue (12m)₹2,368 Cr |
Glenmark Life ScienceGlenmark Life Sciences Limited is an India-based company that is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients (API). The Company’s product portfolio comprises of various therapeutic segments, which include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, gastrointestinal health, oncology, pain management and anti-infectives. Its products include Adapalene, Alogliptin Benzoate, Amiodarone HCl, Esomeprazole Sodium, Eszopiclone, Etoricoxib, Omeprazole, Oxcarbazepine, Zolpidem Tartrate, Zonisamide and Voriconazole. The Company’s products also include Vildagliptin, Aprepitant, Bosentan, Cilostazol, Deferasirox, Fluconazole, Ivacaftor, Pirfenidone, Riluzole, Sucralfate, Ticagrelor, Telmisartan and Umifenovir. The Company’s research and development facilities are located at Mahape, Ankleshwar and Dahej in India and manufacturing facilities are located at Ankleshwar, Dahej, Mohol and Kurkumbh.
Read more
Glenmark Life Science Key indicators
52 week high₹906.00 | 52 week low₹456.00 | P/E ratio19.5 |
P/B ratio4.04 | ROE22.33% | ROCE30.01% |
Dividend yield2.54% | Debt/Equity ratio | EPS38.11 |
Learn more
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
75%
Hold
25%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin30.89% | Net profit margin21.49% |
ROE22.33% | ROA15.43% |
ROCE30.01% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Glenmark Life Science Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Tue, Apr 23 2024 | ₹849.00 | ₹826.25 | -2.75% |
Mon, Apr 22 2024 | ₹815.90 | ₹839.55 | |
Fri, Apr 19 2024 | ₹790.00 | ₹802.65 | |
Thu, Apr 18 2024 | ₹800.05 | ₹800.00 | -0.01% |
Tue, Apr 16 2024 | ₹791.00 | ₹800.00 | |
Mon, Apr 15 2024 | ₹798.00 | ₹791.10 | -0.87% |
Fri, Apr 12 2024 | ₹825.00 | ₹808.90 | -1.99% |
Wed, Apr 10 2024 | ₹817.00 | ₹817.15 |
Events
Corporate actions
Dividend • ₹22.5/share
Ex date 17 Oct 2023
Dividend • ₹21/share
Ex date 24 Mar 2023
Dividend • ₹10.5/share
Ex date 15 Sep 2022
Dividend • ₹10.5/share
Ex date 22 Nov 2021
Learn more